# Americold Realty Trust: financial statements, quarterly

COLD · NYSE · CIK 1455863 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cold.md) · [Financials](/companies/cold/financials.md) · [Filings](/companies/cold/filings.md) · [Insiders](/companies/cold/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cold/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [655](/filings/0001628280-24-046288.md) | [664 d](/filings/0001628280-26-012274.md) | [651](/filings/0001628280-25-023760.md) | [646](/filings/0001628280-25-038864.md) | [660](/filings/0001628280-25-050209.md) | [647 d](/filings/0001628280-26-012274.md) | [614](/filings/0001628280-26-032130.md) | [635](/filings/0001628280-26-054283.md) | [649](/filings/0001628280-25-050209.md) | [643 d](/filings/0001628280-26-012274.md) | [615](/filings/0001628280-26-032130.md) | [648](/filings/0001628280-26-054283.md) |
| Cost of revenue | $m | not reported | not reported | [454](/filings/0001628280-25-023760.md) | [445](/filings/0001628280-25-038864.md) | [465](/filings/0001628280-25-050209.md) | [455 d](/filings/0001628280-26-012274.md) | [423](/filings/0001628280-26-032130.md) | [439](/filings/0001628280-26-054283.md) | [459](/filings/0001628280-25-050209.md) | [442 d](/filings/0001628280-26-012274.md) | [434](/filings/0001628280-26-032130.md) | [450](/filings/0001628280-26-054283.md) |
| Selling, general and administrative | $m | [52.4](/filings/0001628280-24-046288.md) | [57.8 d](/filings/0001628280-26-012274.md) | [65.4](/filings/0001628280-25-023760.md) | [59.5](/filings/0001628280-25-038864.md) | [63.7](/filings/0001628280-25-050209.md) | [66.6 d](/filings/0001628280-26-012274.md) | [69.2](/filings/0001628280-26-032130.md) | [66.9](/filings/0001628280-26-054283.md) | [71.0](/filings/0001628280-25-050209.md) | [62.4 d](/filings/0001628280-26-012274.md) | [71.3](/filings/0001628280-26-032130.md) | [62.9](/filings/0001628280-26-054283.md) |
| Operating income | $m | [33.0](/filings/0001628280-24-046288.md) | [(194) d](/filings/0001628280-26-012274.md) | [41.8](/filings/0001628280-25-023760.md) | [63.4](/filings/0001628280-25-038864.md) | [27.2](/filings/0001628280-25-050209.md) | [(8.4) d](/filings/0001628280-26-012274.md) | [22.2](/filings/0001628280-26-032130.md) | [37.6](/filings/0001628280-26-054283.md) | [16.8](/filings/0001628280-25-050209.md) | [(69.3) d](/filings/0001628280-26-012274.md) | [14.3](/filings/0001628280-26-032130.md) | [(288)](/filings/0001628280-26-054283.md) |
| Interest expense | $m | [35.6](/filings/0001628280-24-046288.md) | [33.7 d](/filings/0001628280-26-012274.md) | [33.4](/filings/0001628280-25-023760.md) | [33.2](/filings/0001628280-25-038864.md) | [34.3](/filings/0001628280-25-050209.md) | [34.5 d](/filings/0001628280-26-012274.md) | [36.1](/filings/0001628280-26-032130.md) | [38.2](/filings/0001628280-26-054283.md) | [33.9](/filings/0001628280-25-050209.md) | [39.5 d](/filings/0001628280-26-012274.md) | [41.5](/filings/0001628280-26-032130.md) | [42.3](/filings/0001628280-26-054283.md) |
| Income tax | $m | [(0.5)](/filings/0001628280-24-046288.md) | [(0.6) d](/filings/0001628280-26-012274.md) | [2.0](/filings/0001628280-25-023760.md) | [(2.5)](/filings/0001628280-25-038864.md) | [(0.8)](/filings/0001628280-25-050209.md) | [(7.1) d](/filings/0001628280-26-012274.md) | [2.5](/filings/0001628280-26-032130.md) | [3.2](/filings/0001628280-26-054283.md) | [(6.2)](/filings/0001628280-25-050209.md) | [(19.9) d](/filings/0001628280-26-012274.md) | [(6.6)](/filings/0001628280-26-032130.md) | [22.7](/filings/0001628280-26-054283.md) |
| Net income | $m | [(2.1)](/filings/0001628280-24-046288.md) | [(227) d](/filings/0001628280-26-012274.md) | [9.7](/filings/0001628280-25-023760.md) | [(64.1)](/filings/0001628280-25-038864.md) | [(3.7)](/filings/0001628280-25-050209.md) | [(36.2) d](/filings/0001628280-26-012274.md) | [(16.4)](/filings/0001628280-26-032130.md) | [1.5](/filings/0001628280-26-054283.md) | [(11.4)](/filings/0001628280-25-050209.md) | [(88.3) d](/filings/0001628280-26-012274.md) | [(13.6)](/filings/0001628280-26-032130.md) | [(343)](/filings/0001628280-26-054283.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001628280-24-046288.md) | not reported | [0.03](/filings/0001628280-25-023760.md) | [(0.23)](/filings/0001628280-25-038864.md) | [(0.01)](/filings/0001628280-25-050209.md) | not reported | [(0.06)](/filings/0001628280-26-032130.md) | [0.01](/filings/0001628280-26-054283.md) | [(0.04)](/filings/0001628280-25-050209.md) | not reported | [(0.05)](/filings/0001628280-26-032130.md) | [(1.19)](/filings/0001628280-26-054283.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001628280-24-046288.md) | not reported | [0.03](/filings/0001628280-25-023760.md) | [(0.23)](/filings/0001628280-25-038864.md) | [(0.01)](/filings/0001628280-25-050209.md) | not reported | [(0.06)](/filings/0001628280-26-032130.md) | [0.01](/filings/0001628280-26-054283.md) | [(0.04)](/filings/0001628280-25-050209.md) | not reported | [(0.05)](/filings/0001628280-26-032130.md) | [(1.19)](/filings/0001628280-26-054283.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [53.8](/filings/0001628280-23-036379.md) | [60.4](/filings/0001628280-25-008770.md) | [59.2](/filings/0001628280-24-022615.md) | [44.2](/filings/0001628280-24-036111.md) | [61.3](/filings/0001628280-24-046288.md) | [47.7](/filings/0001628280-26-012274.md) | [38.9](/filings/0001628280-25-023760.md) | [101](/filings/0001628280-25-038864.md) | [33.3](/filings/0001628280-25-050209.md) | [137](/filings/0001628280-26-054283.md) | [39.8](/filings/0001628280-26-032130.md) | [40.5](/filings/0001628280-26-054283.md) |
| Total assets | $m | [8,014](/filings/0001628280-23-036379.md) | [7,869](/filings/0001628280-25-008770.md) | [7,788](/filings/0001628280-24-022615.md) | [7,802](/filings/0001628280-24-036111.md) | [7,885](/filings/0001628280-24-046288.md) | [7,736](/filings/0001628280-26-012274.md) | [7,825](/filings/0001628280-25-023760.md) | [8,090](/filings/0001628280-25-038864.md) | [8,081](/filings/0001628280-25-050209.md) | [8,122](/filings/0001628280-26-054283.md) | [8,084](/filings/0001628280-26-032130.md) | [7,811](/filings/0001628280-26-054283.md) |
| Total liabilities | $m | [4,067](/filings/0001628280-23-036379.md) | [4,235](/filings/0001628280-25-008770.md) | [4,187](/filings/0001628280-24-022615.md) | [4,333](/filings/0001628280-24-036111.md) | [4,492](/filings/0001628280-24-046288.md) | [4,429](/filings/0001628280-26-012274.md) | [4,606](/filings/0001628280-25-023760.md) | [4,944](/filings/0001628280-25-038864.md) | [5,010](/filings/0001628280-25-050209.md) | [5,200](/filings/0001628280-26-054283.md) | [5,225](/filings/0001628280-26-032130.md) | [5,360](/filings/0001628280-26-054283.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3,930](/filings/0001628280-23-036379.md) | [3,616](/filings/0001628280-25-008770.md) | [3,581](/filings/0001628280-24-022615.md) | [3,448](/filings/0001628280-24-036111.md) | [3,370](/filings/0001628280-24-046288.md) | [3,281](/filings/0001628280-26-012274.md) | [3,190](/filings/0001628280-25-023760.md) | [3,114](/filings/0001628280-25-038864.md) | [3,033](/filings/0001628280-25-050209.md) | [2,884](/filings/0001628280-26-054283.md) | [2,820](/filings/0001628280-26-032130.md) | [2,415](/filings/0001628280-26-054283.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [110 d](/filings/0001628280-24-046288.md) | [173 d](/filings/0001628280-26-012274.md) | [62.0](/filings/0001628280-25-023760.md) | [137 d](/filings/0001628280-25-038864.md) | [50.6 d](/filings/0001628280-25-050209.md) | [163 d](/filings/0001628280-26-012274.md) | [30.2](/filings/0001628280-26-032130.md) | [120 d](/filings/0001628280-26-054283.md) | [78.9 d](/filings/0001628280-25-050209.md) | [130 d](/filings/0001628280-26-012274.md) | [39.9](/filings/0001628280-26-032130.md) | [100 d](/filings/0001628280-26-054283.md) |
| Capital expenditure | $m | [60.3 d](/filings/0001628280-24-046288.md) | [76.2 d](/filings/0001628280-26-012274.md) | [45.8](/filings/0001628280-25-023760.md) | [63.3 d](/filings/0001628280-25-038864.md) | [95.2 d](/filings/0001628280-25-050209.md) | [105 d](/filings/0001628280-26-012274.md) | [113](/filings/0001628280-26-032130.md) | [178 d](/filings/0001628280-26-054283.md) | [144 d](/filings/0001628280-25-050209.md) | [142 d](/filings/0001628280-26-012274.md) | [110](/filings/0001628280-26-032130.md) | [140 d](/filings/0001628280-26-054283.md) |
| Dividends paid | $m | [59.8 d](/filings/0001628280-24-046288.md) | [62.7 d](/filings/0001628280-26-012274.md) | [63.0](/filings/0001628280-25-023760.md) | [63.1 d](/filings/0001628280-25-038864.md) | [63.0 d](/filings/0001628280-25-050209.md) | [62.9 d](/filings/0001628280-26-012274.md) | [63.4](/filings/0001628280-26-032130.md) | [66.2 d](/filings/0001628280-26-054283.md) | [66.1 d](/filings/0001628280-25-050209.md) | [65.6 d](/filings/0001628280-26-012274.md) | [66.1](/filings/0001628280-26-032130.md) | [66.5 d](/filings/0001628280-26-054283.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [270](/filings/0001628280-23-036379.md) | [270](/filings/0001628280-24-022615.md) | [270](/filings/0001628280-24-036111.md) | [278](/filings/0001628280-24-046288.md) | [285](/filings/0001628280-25-023760.md) | [285](/filings/0001628280-25-038864.md) | [285](/filings/0001628280-25-050209.md) | [285](/filings/0001628280-26-032130.md) | [286](/filings/0001628280-26-054283.md) | [286](/filings/0001628280-25-050209.md) | [286](/filings/0001628280-26-032130.md) | [287](/filings/0001628280-26-054283.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 285,480,551 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054283.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.